Lidocaine study in brain tumor surgery may pave way for new treatments
NCT ID NCT04716699
First seen Mar 14, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This study looked at how much of the numbing drug lidocaine gets into brain tumors during surgery for glioblastoma, an aggressive brain cancer. Researchers measured lidocaine levels in the blood and tumor tissue of 12 patients. The goal was to gather information that could help develop new treatments for glioblastoma in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.